Detalhe da pesquisa
1.
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung.
Cell
; 185(1): 113-130.e15, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921774
2.
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.
Cell
; 181(5): 1004-1015.e15, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32375025
3.
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
Nat Immunol
; 22(10): 1306-1315, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417590
4.
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
Immunity
; 55(12): 2405-2418.e7, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356572
5.
From mRNA sensing to vaccines.
Immunity
; 54(12): 2676-2680, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739870
6.
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
Immunity
; 54(8): 1869-1882.e6, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270939
7.
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.
Cell
; 181(6): 1436-1441, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32531248
8.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756549
9.
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med
; 383(20): 1920-1931, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663912
10.
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
N Engl J Med
; 383(25): 2427-2438, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991794
11.
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
N Engl J Med
; 383(16): 1544-1555, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722908
12.
Pre-fusion structure of a human coronavirus spike protein.
Nature
; 531(7592): 118-21, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26935699
13.
Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies.
Proc Natl Acad Sci U S A
; 116(1): 227-232, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518559
14.
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
J Infect Dis
; 224(Supplement_1): S1-S21, 2021 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111271
15.
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses.
J Clin Immunol
; 41(5): 906-913, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725211
16.
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020.
Emerg Infect Dis
; 26(9): 1998-2004, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620182
17.
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.
Proc Natl Acad Sci U S A
; 114(35): E7348-E7357, 2017 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807998
18.
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
N Engl J Med
; 384(15): 1468-1470, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730471
19.
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
J Virol
; 92(10)2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514901
20.
Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort.
J Infect Dis
; 211(4): 590-9, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336728